SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-034557
Filing Date
2021-02-09
Accepted
2021-02-09 17:02:01
Documents
1
Group Members
PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d113365dsc13g.htm SC 13G 66768
  Complete submission text file 0001193125-21-034557.txt   68478
Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-245-5715
Akouos, Inc. (Subject) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91555 | Film No.: 21607432
SIC: 2834 Pharmaceutical Preparations